KILITCH - Kilitch Drugs India

Kilitch Drugs India

KILITCH · Pharma > Pharmaceuticals & Drugs · MD: Mukund P Mehta · Listing date: Sept. 29, 2010 · Employees: 123 · Mumbai · http://www.kilitch.com

Stock Price vs Company Growth

4.1%

7.6%

13.9%

22.2%

63.6%

18.2%

22.1%

10y

25.7%

all

12.2%

🤔 How to analyze this graph?

Last Traded Price

₹ 221 4.1%

157

268

Company Overview

Sales

237 Cr

Growth: 24.4%

Profit after Tax

30.1 Cr

Growth: -0.4%

Small Cap

771 Cr

P/E: 25.1x

Industry P/E: 32.5x

Fundamentals

Sales (Cr)	₹ 237
Growth	24.4%
EBITDA	15.3%
P/S	3.3x
Dividend	0.0%
P/E	25.1x
Book Value	₹ 80.8
PEG Ratio	1.1x
ROE	12.1%
P/B	2.8x

Shareholding Pattern

Institutions

Dipak Kanayalal Shah

2.65 %

Iepf

1.5 %

Llp

0.05 %

Promoters

Kilitch Company (Pharma) Limited

42.6 %

Bhavin Mukund Mehta

12.87 %

Neeta Mukund Mehta

7.14 %

Mukund Mehta

5.72 %

Others

Increase Decrease No change

Company Profile Detailed

Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms. With nearly two decades of creating safe pharmaceutical solutions and the ultimate purpose of making the world a healthier place.Kilitch is one of the largest manufacturers of antibacterial parenteral formulations. It is also one of the largest producers of sterile liquid formulations in small volumes in India.

Belongs to (4 Indices)

Investors (26)

dipak.ka...

dipak.sh...

paresh.p...

Followers (2)

paras5

varsha96